Drug Companies Wait for FDA Guidelines on Social Media Marketing
// Very interesting read about the growing trend of advertising via social media by Pharma… Since social media is consuming more time than TV in some population segments, regulation must definitely exist here too.
This past June, Facebook took industry social media policy into its own hands, no longer allowing drug makers to disable ‘comments’ on their social media pages. The two-way nature of communications permitted in social media, is one of the most difficult barriers for industry to maintain compliance with regulations. By no longer allowing for comments to be monitored, drug makers faced potential legal issues with the reporting of adverse events, negative information and libelous information. While Facebook’s action was consistent with their overall stance on open communication, industry was left with the tough question of whether or not to abandon the idea of online social media, entirely.
(via Good.is)
